Magic mushrooms have recently garnered attention for their potential role in managing mental health disorders, particularly depression. A growing trend involves consuming a consistent dosage of approximately 25 mg of the key compound, available for purchase at a mushroom dispensary. This dosage shows promise in providing relief and could complement conventional depression treatments.
A scholarly study indicates psilocybin, the active ingredient in magic mushrooms, to have positive implications in treating depression.
Main Points:
- Psilocybin can result in a reduction of depression symptoms in as short as eight days.
- The side effects of psilocybin are generally well-managed and usually range from mild to moderate.
- A dose of 25mg psilocybin can create changes in perception, mood variations, increased creativity, and a sense of unity.

Just One Dose Required
A recent study employed a rigorous approach, using a randomized, multi-blinded design to compare a single dose of psilocybin with an active placebo (niacin). The research evaluated the onset, benefits duration, and safety of psilocybin over six weeks.
The Subjects
The study targeted individuals aged 21 to 65 who met the Major Depressive Disorder (MDD) criteria as defined by the DSM-5 (Diagnostic and Statistical Manual of Mental Disorders) and were in the midst of a depressive episode lasting at least 60 days.
The Procedure
Participants were administered a single 25-mg oral dose of psilocybin or a 100-mg dose of niacin. Niacin served as an active placebo, causing an immediate physiological response (flushing) to maintain the blind study’s integrity.
Both the psilocybin and niacin placebo were administered following a standard “set and setting” process. The preparatory sessions, facilitated by two individuals, lasted between 6 and
The dosage period typically lasted between 7 and 10 hours in a relaxed environment. Four hours after the dosage, participants were prompted to ponder their experiences.
Research Findings
Evidence of reduced depression symptoms were visible just eight days post-psilocybin administration. This promising result was consistent throughout the six-week monitoring period. The response and remission rates, as measured by the Montgomery-Asberg Depression Rating Scale (MADRS), were higher relative to other psilocybin and Treatment-Resistant Depression studies.
Psilocybin proved to be more effective in improving psychosocial functioning than niacin. Its usage demonstrated potential in several aspects such as reducing the overall disease severity, mitigating anxiety, decreasing self-reported depressive symptoms, and improving the quality of life.
The majority of participants tolerated the substance well, with only mild to moderate side effects primarily occurring after the first dose. Yet, compared to niacin, psilocybin treatment had more frequent and intense side effects, which is consistent with our current understanding of its impact.
Scientists highlighted that psychedelics like psilocybin could produce side effects that conventional rating scales may not always pick up, or they could reveal previously undetected psychiatric conditions, even as they effectively treat certain disorders.
What Does a 25-mg Dose Mean?
A standard psychedelic dose usually varies from 15 to 25 milligrams of psilocybin (1.5 to 2.5 grams of dried mushrooms), which is the typical dosage for individuals seeking the full psychedelic effects of magic mushrooms.
This dosage can result in changes in perception and mood, increased creativity, and a sense of unity with the environment. While slight visual effects may occur, intense hallucinations are not typical. It’s akin to stepping into a vivid dream-like state where reality merges seamlessly with an array of captivating visual and auditory sensations.
Exhilarating feelings often materialize as dance, gentle movements, or simply succumbing to the psychedelic rhythm. The experience typically lasts from 4 to 8 hours. At this level, visual distortions may become more pronounced as patterns appear to animate and morph, and your surroundings seem to pulsate with energy.
This dosage can be controlled, but it requires a well-managed setting and a calm mindset. It offers a journey full of awe and curiosity, inspiring you to delve into the realm of consciousness. with careful excitement.
- An enhanced perception of color.
- Visual distortions such as moving or “breathing” objects.
- Synesthetic experiences, like “seeing sounds” or “hearing colors”.
- A heightened understanding of music.
- Occasional bursts of laughter.
- Alterations in touch sensations.
- Engagement in self-reflection.
- Feelings of euphoria.
- Distorted perception of time.
- An increase in heart rate and blood pressure.
Products Offered by Magic Mushroom Shops
Magic mushroom shops supply a variety of psilocybin-enhanced products. These stores present a multitude of choices including dried mushrooms, edibles, capsules, and drinks, among other things. Dried mushrooms are particularly favored.
Health Canada recognizes over 200 types of magic mushrooms, with Psilocybe cubensis being a commonly sold type. This strain is offered in various forms, presenting a broad selection for customers, similar to the choices at cannabis dispensaries.
More Shroom Products:
Edibles | Food products like gummies and chocolates infused with psilocybin. Dosing is made easier as the manufacturers mark the quantity per serving. |
Capsules | They are tasteless and can easily be included in your wellness routine. They contain minimal amounts for a mild enhancement to your daily schedule. |
Drinks | Similar to edibles but in a liquid form. They are versatile and come in varieties such as chocolate, coffee, or tea. |
Figuring Out Your Dosage at Magic Mushroom Dispensaries
Although magic mushrooms are not typically used for depression treatment, Canada has taken a progressive step. They have allowed the examination and medical usage of psilocybin, a Schedule I substance under the Controlled Drugs and Substances Act, for specific patients suffering from severe major depressive disorder. This move could potentially benefit tens of thousands navigating the complexities of anxiety and depression while exploring alternative treatment avenues through clinical trials.
Commonly Asked Questions
Can psilocybin be purchased from a What does a medicinal mushroom dispensary offer?
A medicinal mushroom dispensary typically offers products like Reishi, Turkey Tail, and Lion’s Mane. If you’re curious about the world of mushrooms, a magic mushroom online dispensary could be your ideal destination. These dispensaries specialize in a diverse range of mushroom products, including dried mushrooms and other psychedelic substances.
Is a 25 mg dosage effective for depression treatment?
Research on the optimal dosage of psilocybin for treating depression is still in progress. Some studies have examined lower dosages while others have explored higher psilocybin quantities. An approach might be to start with a microdose and gradually increase the dosage.
Can shrooms be purchased in Toronto?
Online mushroom vendors offer the convenience of shopping from anywhere in Canada. Regardless of your province or city, these online platforms ensure delivery right to your doorstep.
What is the most cost-effective product in an online mushroom shop?
Dried mushrooms are typically the first choice for customers because of the variety of quantities available. The price may fluctuate depending on whether you require a smaller quantity like 1 gram or intend to purchase larger amounts. While edibles and other products are fairly priced, they may not be as economical as dried mushrooms.
Can a single dose of shrooms help to alleviate depression?
Some studies suggest that a single application may be enough to lessen depression symptoms. However, it’s essential to remember that study participants also engaged in talk therapy along with the treatment. The combination of psychedelic therapy and therapeutic sessions seems to yield the most effective results.
About the Author
This article was penned by Charles L. Raison et al.; Jeremy D. Coplan, MD and Dorothy P. Reddy, MD; Albert Garcia-Romeu, Frederick S Barrett, Theresa M Carbonaro, Matthew W Johnson, and Roland R Griffiths; Vince Polito.
Richard J. Stevenson, Rebecca Smausz, Joanna Neill, and John Gigg are all contributors.
Affiliated Organizations:
- Usona Institute, located in Fitchburg, Wisconsin
- SUNY Downstate Medical Center, based in Brooklyn, New York
- Neurogenesis Clinics, situated in Brooklyn, New York
- Johns Hopkins University School of Medicine’s Department of Psychiatry and Behavioral Sciences, in Baltimore, MD, USA
- Johns Hopkins University School of Medicine’s Center for Psychedelic and Consciousness Research, located in Baltimore, MD, USA
- Johns Hopkins University School of Medicine’s Department of Neuroscience, based in Baltimore, MD, USA
- Johns Hopkins University School of Medicine’s Department of Psychiatry and Behavioral Sciences, situated in Baltimore, USA
- Macquarie University’s Department of Cognitive Science, located in Sydney, Australia
- Macquarie University’s Department of Psychology, based in Sydney, Australia
- The University of Manchester’s Division of Neuroscience and Experimental Psychology, within the Faculty of Biology, Medicine and Health, located in Manchester, UK
- The University of Manchester’s Division of Pharmacy and Optometry, within the Faculty of Biology, Medicine and Health, based in Manchester, UK
- The Medical Psychedelics Working Group, associated with Drug Science, UK